Sign in

Less potent type-3 dengue strain circulating in city

NEW DELHI: The less virulent type3 strain of dengue is in circulation in Delhi this season, which means few hospitalisations due to the mosquito-borne viral infection.

Published on: Aug 25, 2016, 07:45:28 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

NEW DELHI: The less virulent type3 strain of dengue is in circulation in Delhi this season, which means few hospitalisations due to the mosquito-borne viral infection.

HT Image
HT Image

“The All India Institute of Medical Sciences (AIIMS) has isolated the dengue strain and it is the less potent type-3, which doesn’t cause the deadly dengue haemorrhagic fever or shock syndrome,” said CK Mishra, secretary (health), government of India.

While 311 dengue cases have been reported in the city so far, less than 1% needed hospitalisation. The government so far has reported only two dengue deaths.

“We haven’t had patients requiring blood transfusion. Most of those infected have had self-limiting symptoms that were taken care of with paracetamol and adequate hydration, which says that the weaker strain is in circulation this year,” said Dr Atul Gogia, senior consultant, department of internal medicine, Ganga Ram Hospital.

Another mosquito-borne viral infection— chikungunya — however is spreading rapidly in Delhi this year, with municipal corporations confirming 20 cases so far.

“Technical experts tell us chikungunya will be at the peak of its 6-8 year cycle this year,” said Mishra.

It is a debilitating, though not life-threatening, disease with patients showing symptoms similar to dengue. Typical symptoms include high-grade fever, excruciating joint pain, joint swelling, head and body ache.

The government is looking for ways to streamline reporting of dengue numbers as it comes under a lot of flak for discrepancies in data.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More